Centre Jean Perrin clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
- Minor: DIVAPERF · Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt Trial completed
- Minor: PACTHE-VR · Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment Trial completed
- Notable: NANO-GBM · AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide · Newly Diagnosed Glioblastoma Primary completion pushed from Sep 2025 to Nov 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
Not charted: 11 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 11
Breast Cancer (5) · Head & Neck Cancer (2) · Triple-Negative Breast Cancer (2) · Glioblastoma (1) · Glioma (1) · Lung Cancer (1) · Melanoma (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Ovarian Cancer (1) · Prostate Cancer (1)
Get alerts when Centre Jean Perrin's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.